ACC Recommendations on the Role of Nonstatin Therapies for Lowering LDL-C
In 2021, an expert panel assembled to review gaps in care related to treatments meant to lower LDL-C in patients with atherosclerotic cardiovascular disease.
In 2021, an expert panel assembled to review gaps in care related to treatments meant to lower LDL-C in patients with atherosclerotic cardiovascular disease.
A study was conducted to determine if, compared with hypertension, arterial stiffness is a more accurate predictor of diabetes risk.
A study was conducted to determine the relationship between obesity, age at menopause, and heart failure incidence.
Tamara Horwich, MD, Eugenia Gianos, MD, and Kenneth Fleisher, DDS, reflect on the link between cardiovascular disease and oral health.
A study was conducted to determine the relationship between breast arterial calcification and risk for atherosclerotic cardiovascular disease.
Dennis R. Leahy, MD, shares his POV on the value of making Lp(a) testing universal, not only to inform patients and their clinicians of the high CV risks, but to make way for potential treatments.
Important questions regarding the prevention of CAD remain unanswered.